Adaptive approach to trial design and operation is key, Health Decisions

By Gareth Macdonald

- Last updated on GMT

Related tags Clinical trial

Adaptive approach to trial design and operation is key, Health Decisions
An adaptive approach to both the design and operation of a clinical trial can boost efficiency, reduce timelines and cut costs says Health Decisions' CEO Michael Rosenberg.

Rosenberg spoke with Outsourcing-pharma at DIA Euro Meeting in Monaco and explained that although adaptive clinical trial design is a well established practice, CROs and drugmakers have only "scraped the surface​" in the use of an adaptive approach to trial operations.

He highlighted enrollment as one operational area that could be improved explaining that Health Decisions' research indicates that 76 per cent of adaptive trials meet enrollment timelines compared with just 15 per cent of traditional studies.

The other advantage of an adaptive approach to trial operations is that, unlike adaptive changes at the design level, they do not require regulatory approval and thus give CROs and sponsors direct control over some of the most costly and time consuming aspects of a clinical study.

Related news

Show more

Related products

show more

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Small Molecule development – getting it right

Small Molecule development – getting it right

Content provided by Lonza Small Molecules | 20-Jun-2023 | Insight Guide

Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can...

Related suppliers

Follow us

Products

View more

Webinars